Literature DB >> 8302716

Mixed renal tumor with carcinomatous and fibroleiomyomatous components, associated with angiomyolipoma in the same kidney.

V Canzonieri1, R Volpe, A Gloghini, A Carbone, A Merlo.   

Abstract

A 54-year-old woman, without the stigmas of tuberous sclerosis, underwent radical nephrectomy for simultaneous occurrence of an Angiomyolipoma (AML) and a carcinomatous and fibroleiomyomatous mixed tumor in the same kidney, diagnosed by computerized tomography, selective renal arteriography and anatomopathological examination. The peculiar findings of the mixed neoplasia, characterized by a mixture of carcinomatous and fibroleiomuscular components are stressed. The latter component is considered to be a proliferative element interacting with the carcinomatous one. After review of the pertinent literature, this is the first example of an association of AML and renal cell carcinoma (RCC) in which the RCC is constituted by a mixture of carcinomatous and fibroleiomyomatous cells.

Entities:  

Mesh:

Year:  1993        PMID: 8302716     DOI: 10.1016/S0344-0338(11)81110-6

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Bilateral renal cell carcinoma with leiomyomatous stroma: A rare entity diagnosed synchronously and treated surgically in a staged fashion.

Authors:  Murat Can Kiremit; Ömer Acar; Yeşim Sağlıcan; Tarık Esen
Journal:  Turk J Urol       Date:  2017-12-01

Review 2.  The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.

Authors:  Francesco Massari; Chiara Ciccarese; Ondrej Hes; Michal Michal; Anna Caliò; Michelangelo Fiorentino; Francesca Giunchi; Alessandro D'Amuri; Francesca Sanguedolce; Roberto Sabbatini; Annalisa Guida; Andrea Ardizzoni; Camillo Porta; Roberto Iacovelli; Giampaolo Tortora; Luca Cima; Cinzia Ortega; Alberto Lapini; Guido Martignoni; Matteo Brunelli
Journal:  Pathol Oncol Res       Date:  2017-07-10       Impact factor: 3.201

3.  Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity.

Authors:  M Michal; O Hes; J Nemcova; R Sima; N Kuroda; S Bulimbasic; M Franco; N Sakaida; D Danis; D V Kazakov; C Ohe; M Hora
Journal:  Virchows Arch       Date:  2008-11-20       Impact factor: 4.064

4.  The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process.

Authors:  Fredrik Petersson; Jindrich Branzovsky; Petr Martinek; Marie Korabecna; Bozo Kruslin; Milan Hora; Kvetoslava Peckova; Kevin Bauleth; Kristyna Pivovarcikova; Michal Michal; Marian Svajdler; Maris Sperga; Stela Bulimbasic; Xavier Leroy; Boris Rychly; Sandra Trivunic; Bohuslava Kokoskova; Pavla Rotterova; Miroslav Podhola; Saul Suster; Ondrej Hes
Journal:  Virchows Arch       Date:  2014-05-18       Impact factor: 4.064

5.  [Leiomyomatous renal cell carcinoma : Controversy around a new entity].

Authors:  S Rausch; M Scharpf; H Moch; A Stenzl; J Bedke
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

Review 6.  Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Authors:  Alessia Cimadamore; Liang Cheng; Marina Scarpelli; Francesco Massari; Veronica Mollica; Matteo Santoni; Antonio Lopez-Beltran; Rodolfo Montironi; Holger Moch
Journal:  Transl Androl Urol       Date:  2021-03

7.  Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.

Authors:  Áron Somorácz; Levente Kuthi; Tamás Micsik; Alex Jenei; Adrienn Hajdu; Brigitta Vrabély; Erzsébet Rásó; Zoltán Sápi; Zoltán Bajory; Janina Kulka; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2019-10-26       Impact factor: 3.201

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.